Overview
Yee Chung Cheng, MD, joined the Medial College of Wisconsin in 2004. He is currently an Associate Professor of Medicine in the Division of Hematology and Oncology, and the associate program director of the Hematology and Oncology Fellowship program. Dr. Cheng practices at both Froedtert Hospital/Clinical Cancer Center where he specializes and focuses his research in breast cancer, and at Clement J. Zablocki VA Medical Center where he serves as the Section Chief of Hematology and Oncology.Dr. Cheng has completed his general Hematology and Oncology training at Baylor College of Medicine, Houston, Texas and also a specialized Blood and Marrow Transplantation training at the University of Texas M. D. Anderson Cancer Center, Houston, Texas.His initial research interest was in the potential use of high-dose chemotherapy with hematopoietic stem cell transplantation in breast cancer. Currently his research interest is in the development of clinical trials focus on the investigative use of chemotherapy and/or novel therapy in high risk breast cancer included triple negative breast cancer or inflammatory breast cancer.Together with his breast cancer colleagues at Froedtert Hospital/Clinical Cancer Center, Dr. Cheng has formed an inflammatory breast cancer (IBC) team to join the international IBC Connect organization led by the University of Texas M. D. Anderson Cancer Center, Houston, Texas. With the close collaboration with other renowned cancer centers in the world, we aim to provide the state of art management to inflammatory breast cancer in the state of Wisconsin.
Dr. Cheng is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
Dr. Cheng is board certified in Hematology, Internal Medicine, and Medical Oncology. He is actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 5 clinical trials. Dr. Cheng is currently accepting new patients.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8800 West Doyne Ave., Milwaukee, WI 53226
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Clinical Cancer Center - Froedtert Hospital
John Charlson is an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Charlson is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Dr. Charlson is board certified in Medical Oncology. Dr. Charlson is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Dr. Kurzrock is a world-renowned leader in precision oncology and rare cancers research. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair for the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading eight life-changing drugs to FDA approval. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work. Dr. Kurzrock is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Tissue Biopsy. Dr. Kurzrock is board certified in Internal Medicine and Medical Oncology. Dr. Kurzrock is currently accepting new patients.
Froedtert And The Medical College Of Wisconsin Froedtert Hospital
Parameswaran Hari is an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Hari is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, Bone Marrow Transplant, and Splenectomy.
Frequently Asked Questions about Dr. Yee C. Cheng
How do I make an appointment with Dr. Yee C. Cheng?
You can book an appointment with Dr. Yee C. Cheng by calling their office at 866-680-0505. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Yee C. Cheng a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yee C. Cheng is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Yee C. Cheng specialize in?
While Dr. Yee C. Cheng is a Oncology, they have specific expertise in Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Yee C. Cheng participate in research or clinical trials?
Yes. Dr. Yee C. Cheng has published 23 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Yee C. Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Yee C. Cheng accept my insurance?
Dr. Yee C. Cheng accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 866-680-0505 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Cheng isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Cheng isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Cheng isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Cheng isDistinguished. Learn about Paget Disease of the Breast.
- Experienced
- AgranulocytosisDr. Cheng isExperienced. Learn about Agranulocytosis.
- Breast Cancer in MenDr. Cheng isExperienced. Learn about Breast Cancer in Men.
- Chronic Familial NeutropeniaDr. Cheng isExperienced. Learn about Chronic Familial Neutropenia.
- HER-2 Positive Breast CancerDr. Cheng isExperienced. Learn about HER-2 Positive Breast Cancer.
- Intraductal PapillomaDr. Cheng isExperienced. Learn about Intraductal Papilloma.
- Juvenile Primary OsteoporosisDr. Cheng isExperienced. Learn about Juvenile Primary Osteoporosis.